On September 10-13, Katarzyna Klas from our team attended the Global Evidence Summit 2024 in Prague. She presented the results of the study “Characteristics and Reporting of Seamless Early-Phase Trials in Oncology – A Cross-Sectional Analysis of Trials Registered on ClinicalTrials.gov”. View her poster presentation here.